665 related articles for article (PubMed ID: 15020330)
21. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
22. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
23. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
24. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
25. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.
Turunen S; Huhtakangas J; Nousiainen T; Valkealahti M; Melkko J; Risteli J; Lehenkari P
Arthritis Res Ther; 2016 Oct; 18(1):239. PubMed ID: 27765067
[TBL] [Abstract][Full Text] [Related]
26. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Lee HJ; Joo M; Abdolrasulnia R; Young DG; Choi I; Ware LB; Blackwell TS; Christman BW
J Biol Chem; 2010 Dec; 285(51):39655-62. PubMed ID: 20937835
[TBL] [Abstract][Full Text] [Related]
27. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
28. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
29. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
Yamada R; Suzuki A; Chang X; Yamamoto K
Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
[TBL] [Abstract][Full Text] [Related]
30. Dynamic expression of peptidylarginine deiminase 2 in human monocytic leukaemia THP-1 cells during macrophage differentiation.
Hojo-Nakashima I; Sato R; Nakashima K; Hagiwara T; Yamada M
J Biochem; 2009 Oct; 146(4):471-9. PubMed ID: 19564157
[TBL] [Abstract][Full Text] [Related]
31. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
32. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.
Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R
Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970
[TBL] [Abstract][Full Text] [Related]
33. Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.
Hensen SM; Pruijn GJ
Mol Cell Proteomics; 2014 Feb; 13(2):388-96. PubMed ID: 24298040
[TBL] [Abstract][Full Text] [Related]
34. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
Suzuki A; Yamada R; Yamamoto K
Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
[TBL] [Abstract][Full Text] [Related]
35. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
36. Perspective on Protein Arginine Deiminase Activity-Bicarbonate Is a pH-Independent Regulator of Citrullination.
Zhou Y; Mittereder N; Sims GP
Front Immunol; 2018; 9():34. PubMed ID: 29403504
[TBL] [Abstract][Full Text] [Related]
37. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome.
Nissinen R; Paimela L; Julkunen H; Tienari PJ; Leirisalo-Repo M; Palosuo T; Vaarala O
Scand J Rheumatol; 2003; 32(6):337-42. PubMed ID: 15080264
[TBL] [Abstract][Full Text] [Related]
38. The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.
Thomas MA; Naik P; Wang H; Giles JT; Girgis AA; Kim SY; Johnson TP; Curran AM; Crawford JD; Jahanbani S; Bingham CO; Robinson WH; Na CH; Darrah E
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2304199121. PubMed ID: 38630712
[TBL] [Abstract][Full Text] [Related]
39. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
40. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]